LCM
SGMO

Laurion Capital Management’s SANGAMO THERAPEUTICS INC SGMO Stock Holding History

Laurion Capital Management’s Portfolio SGMO Stock Details SGMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-67,787
Closed -$730K – 1253
2019
Q2 		$730K Buy
+67,787
New +$721K 0.01% 620
2014
Q2 		– Sell
-105,000
Closed -$1.9M – 337
2014
Q1 		$1.9M Buy
+105,000
New +$2.02M 0.07% 153

Other funds holding SGMO

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Laurion Capital Management's SGMO Position: Q3 2019 in Review

Laurion Capital Management sold out of SANGAMO THERAPEUTICS INC (SGMO) in Q3 2019, closing a stake of 67,787 shares — an estimated $730K sold.

Laurion Capital Management first reported a position in SGMO in Q1 2014 and held it in 2 quarters. The position peaked at $1.9M in Q1 2014. 184 funds tracked by Wall St. Rank hold SGMO as of Q3 2019.

  • Laurion Capital Management reported no remaining SANGAMO THERAPEUTICS INC position as of Q3 2019 after selling out during the quarter.
  • Laurion Capital Management sold 67,787 SANGAMO THERAPEUTICS INC shares in Q3 2019, an estimated $730K.
  • Laurion Capital Management first reported a position in SANGAMO THERAPEUTICS INC in Q1 2014 and held it in 2 quarters.
  • Laurion Capital Management's SANGAMO THERAPEUTICS INC position peaked at $1.9M in Q1 2014.
  • 184 funds tracked by Wall St. Rank held SANGAMO THERAPEUTICS INC as of Q3 2019.

Based on Laurion Capital Management's 13F filing for Q3 2019, filed 13 Nov 2019.